"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
- Patient Information:
Details with Side Effects
Rezulin (troglitazone (removed from the us market 3/21/00)) is contraindicated in patients with known hypersensitivity or allergy to Rezulin (troglitazone (removed from the us market 3/21/00)) or any of its components.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Rezulin Information
Report Problems to the Food and Drug Administration
Find out what women really need.